Quarterly Review: New Technologies, Markets a Key Focus for Big Research Tools Firms | GenomeWeb

By Tony Fong

NEW YORK (GenomeWeb News) – By now, most life science tool companies have reported their earnings results for the most recently completed quarter. As many of the firms covered by GenomeWeb Daily News reported jumps in revenues year over year, with some improving substantially, many singled out the performance of technologies such as next-generation sequencers, mass spectrometers, and PCR systems not only as revenue drivers for the quarter just ended but also for the future.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: researchers identify the characteristic genomic features of clear cell renal cell carcinoma, and more.

A technology that has the potential to make species go extinct could be used against the Zika virus. 

University of the Republic postdoc Victor Morais says researchers should be careful of the open access journals they choose to publish in.

If science funding agencies can talk tough about sexual harassers, shouldn't they also put their talk into action?